Academic Unit of Musculoskeletal Disease, University of Leeds, Leeds LS7 4SA, UK.
J Rheumatol. 2011 Mar;38(3):526-9. doi: 10.3899/jrheum.101114.
At the 2009 annual meeting of GRAPPA (Group for Assessment of Psoriasis and Psoriatic Arthritis) in Stockholm, Sweden, 15 fellows involved in research in psoriatic disease were invited to present their work at a Trainees Symposium, which was also attended by members of the GRAPPA Faculty Committee. All of the fellows held poster sessions of their work and 4 of them gave oral presentations, including identification of soluble biomarkers for psoriatic arthritis (PsA), validation of minimal disease activity criteria for PsA, disease progression using the modified Sharp score, and discussion of a new composite disease activity score for PsA. Senior GRAPPA members also instructed the fellows on other composite scoring methods and on training videos and other GRAPPA projects to date. All of the posters and presentations from the Trainees Symposium are summarized herein.
在瑞典斯德哥尔摩举行的 2009 年 GRAPPA(评估银屑病和银屑病关节炎组织)年会上,15 名参与银屑病研究的研究员应邀在学员研讨会上展示他们的工作,GRAPPA 教师委员会的成员也出席了会议。所有研究员都展示了他们的工作海报,其中 4 人进行了口头报告,包括鉴定银屑病关节炎(PsA)的可溶性生物标志物、验证 PsA 的最小疾病活动标准、使用改良 Sharp 评分评估疾病进展,以及讨论新的 PsA 综合疾病活动评分。资深 GRAPPA 成员还指导研究员了解其他综合评分方法以及培训视频和迄今为止的其他 GRAPPA 项目。学员研讨会的所有海报和演示文稿均在此处总结。